GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

Convatec announced that it received FDA approval for the delivery of a Parkinson's disease therapy through its Neria Guard ...

(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

LifePlus announced the clinical validation of its non-invasive and cuffless wearable for continuous glucose and blood ...

The system — similar to continuous glucose monitoring (CGM) uses a new method of continuously sensing specific chemistry ...

Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...